ArticleChembiochem : a European journal of chemical biology2025
Model-Based Optimization of Fed-Batch In Vitro Transcription.
Article in Chembiochem : a European journal of chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Modular Mechanistic In Silico Model for In Vitro Transcription Process Yield and Product Quality Prediction.Biotechnology and bioengineering · 2026Article
- Model-Based Optimization of Fed-Batch In Vitro Transcription.Chembiochem : a European journal of chemical biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Recent developments in RNA vaccines and therapeutics have motivated the need for process engineering strategies to optimize the in vitro transcription (IVT) reaction for RNA synthesis. Specifically, practitioners seek to maximize the production of RNA and the incorporation of the 5-prime cap to the end of each RNA molecule while minimizing the use of expensive reagents. Fed-batch IVT is a promising technique for achieving these goals but is difficult to optimize by purely experimental means. Herein, a mechanistic model for fed-batch IVT is developed and it is used to develop optimized fed-batch protocols to maximize the formation of RNA while controlling concentrations of nucleoside triphosphates. On a model sequence that has been shown to be sensitive to salt concentrations, this approach can produce twice as much RNA as a heuristic approach. In addition, it is observed and characterized for the first time the formation of magnesium phosphate crystals during the IVT reaction. Strategies informed by thermodynamic modeling are developed to prevent this undesired crystallization during fed-batch IVT. Finally, co-transcriptional capping is incorporated into the model-based optimization approach and a strategy to maximize RNA formation is developed while maintaining a high level of 5-prime cap incorporation and minimizing the use of cap analogs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.